Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | SRC | P12931 | 3/20 | 0.42 |
| ▸ | ZAP70 | P43403 | 3/20 | 0.42 |
| ▸ | SYK | P43405 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | PPIA | P62937 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16119591 | 0.83 | PLA2G7 (0.54) | PLA2G7MEN1KMT2AMAPTRAB9A | |
| SCHEMBL17397927 | 0.76 | PLA2G7 (0.49) | PLA2G7MEN1KMT2AMAPTRAB9A | |
| SCHEMBL4238370 | 0.74 | PLA2G7 (0.60) | PLA2G7MEN1KMT2AMAPTRAB9A | |
| SCHEMBL5762561 | 0.73 | PLA2G7 (0.58) | PLA2G7MEN1KMT2AMAPTRAB9A | |
| SCHEMBL1883755 | 0.71 | MAPT (0.79) | MEN1KMT2AMAPTRAB9AMAPK1 | |
| SCHEMBL11996127 | 0.70 | MAPT (0.58) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL15871973 | 0.70 | MAPT (0.58) | MEN1KMT2AMAPTRAB9AMAPK1 | |
| SCHEMBL12070457 | 0.70 | MAPT (0.58) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL851128 | 0.69 | PLA2G7 (0.54) | PLA2G7MEN1KMT2AMAPTRAB9A | |
| SCHEMBL20529581 | 0.69 | PLA2G7 (0.70) | PLA2G7MEN1KMT2AMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3554470-B1 | COSMETIC COMPOSITIONS COMPRISING HYALURONIC ACID | ELC MAN LLC (US) | 2023-07-26 | — | — | EP | disclosed |
| CN-110381918-B | Cosmetic composition | ELC 管理有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | ELC MANAGEMENT LLC (US) | 2022-04-05 | — | — | US | disclosed |
| CN-104797237-B | Methods and compositions for improving selective catabolism in cells on the surface of keratin | ELC 管理有限责任公司 | 2020-11-24 | — | — | CN | disclosed |
| US-20200329844-A1 | Cosmetic Compositions | ELC MAN LLC (US) | 2020-10-22 | — | — | US | disclosed |
| EP-2941241-B1 | METHOD AND COMPOSITIONS FOR IMPROVING SELECTIVE CATABOLYSIS AND VIABILITY IN CELLS OF KERATIN SURFACES | ELC MAN LLC (US) | 2020-10-21 | — | — | EP | disclosed |
| CN-111494253-A | Methods and compositions for improving selective catabolism and viability in cells on the surface of keratin | ELC 管理有限责任公司 | 2020-08-07 | — | — | CN | disclosed |
| US-10660420-B2 | Cosmetic compositions | ELC MANAGEMENT LLC (US) | 2020-05-26 | — | — | US | disclosed |
| EP-3554470-A2 | COSMETIC COMPOSITIONS | ELC Management LLC (US) | 2019-10-23 | — | — | EP | disclosed |
| EP-3538064-A1 | TOPICAL COMPOSITIONS AND METHODS FOR STIMULATING MIR-146A IN SKIN CELLS | ELC Management LLC (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2016144569-A1 | METHODS AND COMPOSITIONS FOR TREATING SKIN TO RESOLVE INFLAMMATION AND SCREENING FOR ACTIVES THAT STIMULATE PRO-RESOLUTION PATHWAYS | ELC MANAGEMENT LLC (US) | 2016-09-15 | — | — | WO | disclosed |
| EP-2941241-A1 | METHOD AND COMPOSITIONS FOR IMPROVING SELECTIVE CATABOLYSIS AND VIABILITY IN CELLS OF KERATIN SURFACES | ELC Management LLC (US) | 2015-11-11 | — | — | EP | disclosed |
| US-20150313830-A1 | Method And Compositions For Improving Selective Catabolysis And Viability In Cells Of Keratin Surfaces | ELC MAN LLC (US) | 2015-11-05 | — | — | US | disclosed |
| CN-104902872-A | Methods and compositions for improving selective catabolism and viability in cells on the surface of keratin | ELC MAN LLC | 2015-09-09 | — | — | CN | disclosed |
| EP-2897582-A1 | METHOD AND COMPOSITIONS FOR IMPROVING SELECTIVE CATABOLYSIS IN CELLS OF KERATIN SURFACES | ELC Management LLC (US) | 2015-07-29 | — | — | EP | disclosed |
| CN-104797237-A | Methods and compositions for improving selective catabolism in cells on the surface of keratin | ELC MAN LLC | 2015-07-22 | — | — | CN | disclosed |
| US-20150071895-A1 | Method And Compositions For Improving Selective Catabolysis in Cells Of Keratin Surfaces | PERNODET NADINE A (US) | 2015-03-12 | — | — | US | disclosed |
| WO-2014107411-A1 | METHOD AND COMPOSITIONS FOR IMPROVING SELECTIVE CATABOLYSIS AND VIABILITY IN CELLS OF KERATIN SURFACES | ELC MANAGEMENT LLC (US) | 2014-07-10 | — | — | WO | disclosed |
| US-20140193391-A1 | Method And Compositions For Improving Selective Catabolysis And Viability In Cells Of Keratin Surfaces | ELC MAN LLC (US) | 2014-07-10 | — | — | US | disclosed |
| WO-2014043009-A1 | METHOD AND COMPOSITIONS FOR IMPROVING SELECTIVE CATABOLYSIS IN CELLS OF KERATIN SURFACES | ELC MANAGEMENT LLC (US) | 2014-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150313830-A1 | Method And Compositions For Improving Selective Catabolysis And Viability In Cells Of Keratin Surfaces | KRT18, CTSA, UNG | PLA2G7 2946/4885MEN1 4832/4885KMT2A 2162/4885 |
| US-10660420-B2 | Cosmetic compositions | CD44, CUTA, MSH6 | PLA2G7 2174/4885MEN1 1503/4885KMT2A 1486/4885 |
| US-20150071895-A1 | Method And Compositions For Improving Selective Catabolysis in Cells Of Keratin Surfaces | KRT18, ATG7, SQSTM1 | PLA2G7 3106/4885MEN1 4563/4885KMT2A 1686/4885 |
| US-20200329844-A1 | Cosmetic Compositions | CD44, CUTA, MSH6 | PLA2G7 2174/4885MEN1 1503/4885KMT2A 1486/4885 |
| US-20140193391-A1 | Method And Compositions For Improving Selective Catabolysis And Viability In Cells Of Keratin Surfaces | KRT18, BECN1, CTSA | PLA2G7 2654/4885MEN1 4543/4885KMT2A 1933/4885 |
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | CD44, CUTA, MSH6 | PLA2G7 2338/4885MEN1 1167/4885KMT2A 1872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.